NM Logo.jpg
Navios Maritime Holdings Inc.’s Tender Offer Deadline is midnight on June 7, 2024 to receive $4.75 in Cash for All Holders of ADSs (Series G & H)
May 23, 2024 08:30 ET | Navios Maritime Holdings, Inc.
GRAND CAYMAN, Cayman Islands, May 23, 2024 (GLOBE NEWSWIRE) -- Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) today provided a reminder of its continuing previously announced...
CG Logo.jpg
Form 8.3 - [LOK'N STORE GROUP PLC - 22 05 2024] - (CGWL)
May 23, 2024 08:30 ET | Canaccord Genuity Wealth Limited
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...
logo.jpg
Saratoga Investment Corp. Increases Quarterly Dividend by $0.01, or 1.4%, to $0.74 per Share for the Fiscal First Quarter Ended May 31, 2024
May 23, 2024 08:30 ET | Saratoga Investment Corp
                                                      Contact: Henri Steenkamp                                                            Saratoga Investment...
Skyquest Logo
High Emphasis on Enhancement of Digital Security will Help Blockchain Market Transcend the USD 87,011.20 Million Mark by 2031-end
May 23, 2024 08:30 ET | SkyQuest Technology Consulting Pvt. Ltd.
Westford,USA, May 23, 2024 (GLOBE NEWSWIRE) -- Blockchain technology is projected to revolutionize the digital world through its decentralized approach and high security. Increasing incidence of...
allogene.png
Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
May 23, 2024 08:30 ET | Allogene Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T...
inozyme_logo.jpg
Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences
May 23, 2024 08:30 ET | Inozyme Pharma Inc.
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for...
Bridgeline_Finance_Yahoo 1200x628 (2).jpg
Colonial Electric Supply Chooses Bridgeline’s AI-Powered HawkSearch on Optimizely
May 23, 2024 08:30 ET | Bridgeline Digital, Inc.
WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, today announced Colonial Electric Supply, a large, independent,...
4534760A-1E07-4934-91F0-5C177AFC1F4E.png
KULR CEO Michael Mo Reduces Cash Salary to Better Align with Shareholder Value Creation
May 23, 2024 08:30 ET | KULR Technology Group, Inc.
KULR’s compensation committee approved a voluntary request by CEO Michael Mo to reduce the cash component of his compensation by 33%.
logo-qlik-lg_vpuyn2.png
ETR Survey Highlights Urgent Need for Expertise in Leveraging Generative AI on Unstructured Data
May 23, 2024 08:30 ET | Qlik Technologies, Inc.
PHILADELPHIA, May 23, 2024 (GLOBE NEWSWIRE) -- Qlik®, a global leader in data integration, analytics, and artificial intelligence (AI), today announced new research revealing that while enterprises...
MnM_logo_TM_JPG.JPG
Injectable Drug Delivery Market is Expected to Reach $1139.4 billion | MarketsandMarkets™
May 23, 2024 08:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, May 23, 2024 (GLOBE NEWSWIRE) -- Injectable Drug Delivery market in terms of revenue was estimated to be worth $754.5 billion in 2024 and is poised to reach $1139.4 billion by 2029, growing...